Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
- PMID: 23993280
- DOI: 10.1016/S0140-6736(13)61611-6
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
Abstract
Background: We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) to estimate the burden of disease attributable to mental and substance use disorders in terms of disability-adjusted life years (DALYs), years of life lost to premature mortality (YLLs), and years lived with disability (YLDs).
Methods: For each of the 20 mental and substance use disorders included in GBD 2010, we systematically reviewed epidemiological data and used a Bayesian meta-regression tool, DisMod-MR, to model prevalence by age, sex, country, region, and year. We obtained disability weights from representative community surveys and an internet-based survey to calculate YLDs. We calculated premature mortality as YLLs from cause of death estimates for 1980-2010 for 20 age groups, both sexes, and 187 countries. We derived DALYs from the sum of YLDs and YLLs. We adjusted burden estimates for comorbidity and present them with 95% uncertainty intervals.
Findings: In 2010, mental and substance use disorders accounted for 183·9 million DALYs (95% UI 153·5 million-216·7 million), or 7·4% (6·2-8·6) of all DALYs worldwide. Such disorders accounted for 8·6 million YLLs (6·5 million-12·1 million; 0·5% [0·4-0·7] of all YLLs) and 175·3 million YLDs (144·5 million-207·8 million; 22·9% [18·6-27·2] of all YLDs). Mental and substance use disorders were the leading cause of YLDs worldwide. Depressive disorders accounted for 40·5% (31·7-49·2) of DALYs caused by mental and substance use disorders, with anxiety disorders accounting for 14·6% (11·2-18·4), illicit drug use disorders for 10·9% (8·9-13·2), alcohol use disorders for 9·6% (7·7-11·8), schizophrenia for 7·4% (5·0-9·8), bipolar disorder for 7·0% (4·4-10·3), pervasive developmental disorders for 4·2% (3·2-5·3), childhood behavioural disorders for 3·4% (2·2-4·7), and eating disorders for 1·2% (0·9-1·5). DALYs varied by age and sex, with the highest proportion of total DALYs occurring in people aged 10-29 years. The burden of mental and substance use disorders increased by 37·6% between 1990 and 2010, which for most disorders was driven by population growth and ageing.
Interpretation: Despite the apparently small contribution of YLLs--with deaths in people with mental disorders coded to the physical cause of death and suicide coded to the category of injuries under self-harm--our findings show the striking and growing challenge that these disorders pose for health systems in developed and developing regions. In view of the magnitude of their contribution, improvement in population health is only possible if countries make the prevention and treatment of mental and substance use disorders a public health priority.
Funding: Queensland Department of Health, National Health and Medical Research Council of Australia, National Drug and Alcohol Research Centre-University of New South Wales, Bill & Melinda Gates Foundation, University of Toronto, Technische Universität, Ontario Ministry of Health and Long Term Care, and the US National Institute of Alcohol Abuse and Alcoholism.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Comment in
-
The global burden of drug use and mental disorders.Lancet. 2013 Nov 9;382(9904):1540-2. doi: 10.1016/S0140-6736(13)61781-X. Epub 2013 Aug 29. Lancet. 2013. PMID: 23993279 No abstract available.
-
Developing accuracy when estimating Global Burden of Disease (GBD) in mental and substance use disorders using complex research methodology, refined data analysis and community participation.Evid Based Ment Health. 2014 Nov;17(4):105. doi: 10.1136/eb-2013-101713. Epub 2014 Mar 25. Evid Based Ment Health. 2014. PMID: 24667733 No abstract available.
-
Hohe globale Belastung durchpsychische Erkrankungen.Gesundheitswesen. 2014 Apr;76(4):181. doi: 10.1055/s-0034-1374642. Gesundheitswesen. 2014. PMID: 24892181 German. No abstract available.
-
Some of the burden of eating disorders is still hidden.Lancet Psychiatry. 2021 Apr;8(4):263-264. doi: 10.1016/S2215-0366(21)00080-8. Epub 2021 Mar 3. Lancet Psychiatry. 2021. PMID: 33675689 Free PMC article. No abstract available.
Similar articles
-
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10. Lancet Psychiatry. 2022. PMID: 35026139 Free PMC article.
-
Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010.Lancet. 2013 Nov 9;382(9904):1564-74. doi: 10.1016/S0140-6736(13)61530-5. Epub 2013 Aug 29. Lancet. 2013. PMID: 23993281 Review.
-
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17. Lancet. 2024. PMID: 38642570 Free PMC article.
-
The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.Lancet. 2024 Dec 7;404(10469):2314-2340. doi: 10.1016/S0140-6736(24)01446-6. Lancet. 2024. PMID: 39645376 Free PMC article.
-
The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010.PLoS One. 2015 Feb 6;10(2):e0116820. doi: 10.1371/journal.pone.0116820. eCollection 2015. PLoS One. 2015. PMID: 25658103 Free PMC article.
Cited by
-
MeHA: A Computational Framework in Revealing the Genetic Basis of Animal Mental Health Traits Under an Intensive Farming System-A Case Study in Pigs.Biology (Basel). 2024 Oct 21;13(10):843. doi: 10.3390/biology13100843. Biology (Basel). 2024. PMID: 39452151 Free PMC article.
-
Effect of a Novel Brief Motivational Intervention for Alcohol-Intoxicated Young Adults in the Emergency Department: A Randomized Clinical Trial.JAMA Netw Open. 2022 Oct 3;5(10):e2237563. doi: 10.1001/jamanetworkopen.2022.37563. JAMA Netw Open. 2022. PMID: 36269355 Free PMC article. Clinical Trial.
-
The noradrenergic paradox: implications in the management of depression and anxiety.Neuropsychiatr Dis Treat. 2016 Mar 1;12:541-57. doi: 10.2147/NDT.S91311. eCollection 2016. Neuropsychiatr Dis Treat. 2016. PMID: 27042068 Free PMC article. Review.
-
The Potential Influence of Group Membership on Outcomes in Indicated Cognitive-Behavioral Adolescent Depression Prevention.Int J Environ Res Public Health. 2020 Sep 9;17(18):6553. doi: 10.3390/ijerph17186553. Int J Environ Res Public Health. 2020. PMID: 32916855 Free PMC article.
-
Music Streaming Services as Adjunct Therapies for Depression, Anxiety, and Bipolar Symptoms: Convergence of Digital Technologies, Mobile Apps, Emotions, and Global Mental Health.Front Public Health. 2016 Sep 30;4:217. doi: 10.3389/fpubh.2016.00217. eCollection 2016. Front Public Health. 2016. PMID: 27747209 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical